Literature DB >> 19197288

Breaking into bone biology: target practice.

Yongwon Choi1, Matthew C Walsh, Joseph R Arron.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19197288      PMCID： PMC2742415          DOI： 10.1038/nm0209-144

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  8 in total

Review 1.  Osteoclast-derived activity in the coupling of bone formation to resorption.

Authors:  T John Martin; Natalie A Sims
Journal:  Trends Mol Med       Date:  2005-02       Impact factor: 11.951

Review 2.  Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems.

Authors:  Hiroshi Takayanagi
Journal:  Nat Rev Immunol       Date:  2007-04       Impact factor: 53.106

Review 3.  Osteoimmunology: interplay between the immune system and bone metabolism.

Authors:  Matthew C Walsh; Nacksung Kim; Yuho Kadono; Jaerang Rho; Soo Young Lee; Joseph Lorenzo; Yongwon Choi
Journal:  Annu Rev Immunol       Date:  2006       Impact factor: 28.527

4.  Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals.

Authors:  Masahiro Shinohara; Takako Koga; Kazuo Okamoto; Shinya Sakaguchi; Kimiko Arai; Hisataka Yasuda; Toshiyuki Takai; Tatsuhiko Kodama; Tomohiro Morio; Raif S Geha; Daisuke Kitamura; Tomohiro Kurosaki; Wilfried Ellmeier; Hiroshi Takayanagi
Journal:  Cell       Date:  2008-03-07       Impact factor: 41.582

5.  Cell fusion in osteoclasts plays a critical role in controlling bone mass and osteoblastic activity.

Authors:  Ryotaro Iwasaki; Ken Ninomiya; Kana Miyamoto; Toru Suzuki; Yuiko Sato; Hiromasa Kawana; Taneaki Nakagawa; Toshio Suda; Takeshi Miyamoto
Journal:  Biochem Biophys Res Commun       Date:  2008-10-24       Impact factor: 3.575

6.  Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial.

Authors:  Jacques P Brown; Richard L Prince; Chad Deal; Robert R Recker; Douglas P Kiel; Luiz H de Gregorio; Peyman Hadji; Lorenz C Hofbauer; Jose M Alvaro-Gracia; Huei Wang; Matthew Austin; Rachel B Wagman; Richard Newmark; Cesar Libanati; Javier San Martin; Henry G Bone
Journal:  J Bone Miner Res       Date:  2009-01       Impact factor: 6.741

7.  Cathepsin K-dependent toll-like receptor 9 signaling revealed in experimental arthritis.

Authors:  Masataka Asagiri; Toshitake Hirai; Toshihiro Kunigami; Shunya Kamano; Hans-Jürgen Gober; Kazuo Okamoto; Keizo Nishikawa; Eicke Latz; Douglas T Golenbock; Kazuhiro Aoki; Keiichi Ohya; Yuuki Imai; Yasuyuki Morishita; Kohei Miyazono; Shigeaki Kato; Paul Saftig; Hiroshi Takayanagi
Journal:  Science       Date:  2008-02-01       Impact factor: 47.728

Review 8.  Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy.

Authors:  R Graham G Russell; Zhidao Xia; James E Dunford; Udo Oppermann; Aaron Kwaasi; Philippa A Hulley; Kathryn L Kavanagh; James T Triffitt; Mark W Lundy; Roger J Phipps; Bobby L Barnett; Fraser P Coxon; Michael J Rogers; Nelson B Watts; Frank H Ebetino
Journal:  Ann N Y Acad Sci       Date:  2007-11       Impact factor: 5.691
  8 in total
  2 in total

1.  The BRIC-GARN Meeting 2011: of mice and men.

Authors:  David S Pisetsky
Journal:  Arthritis Res Ther       Date:  2012-02-24       Impact factor: 5.156

2.  Roles of Enhancer RNAs in RANKL-induced Osteoclast Differentiation Identified by Genome-wide Cap-analysis of Gene Expression using CRISPR/Cas9.

Authors:  Yukako Sakaguchi; Keizo Nishikawa; Shigeto Seno; Hideo Matsuda; Hiroshi Takayanagi; Masaru Ishii
Journal:  Sci Rep       Date:  2018-05-14       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.